Acrivon Therapeutics, Inc. ACRV
2.10
(0.02)
(0.94%)
as of 25 Sep
- Market cap
- $90.9M
- P/E
- 0.0×
Follow ACRV
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
7.99 | 8.98 | 7.69 | 8.75 |
+8 more quarters Free account |
Net Debt/EBITDA |
4.94 | 5.05 | 6.04 | 6.67 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.83 | 1.08 | 0.80 | 0.67 | |
Capex/Depreciation |
(0.19) | (0.03) | (0.45) | (2.85) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.36) | (0.53) | (0.40) | (0.34) | |
Cash per Share |
2.15 | 2.52 | 3.08 | 3.35 | |
Shareholders Equity per Share |
2.07 | 2.47 | 2.92 | 3.34 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.07 | 2.47 | 2.92 | 3.34 | |
Free Cash Flow |
(14.95) | (20.55) | (15.46) | (13.18) | |
Working Capital |
80.05 | 88.17 | 104.78 | 115.47 | |
Capital Expenditures |
(0.09) | (0.01) | (0.22) | (0.90) | |
Net Current Asset Value |
79.07 | 86.90 | 103.24 | 113.67 | |
| Other line items | |||||
Quick Ratio |
7.86 | 8.84 | 7.57 | 8.68 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.36) | (0.53) | (0.40) | (0.32) | |
Capex per Share |
0.00 | 0.00 | (0.01) | (0.02) | |
Average Payables |
1.01 | 2.43 | 1.52 | 1.25 | |
Average Assets |
128.84 | 142.09 | 163.15 | 179.99 | |
Average Common Equity |
114.85 | 127.95 | 144.65 | 162.75 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates